1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Granulocytic Leukemia, Chronic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berg, A; Le Blanc, K; Palmblad, J; Samuelsson, J | 1 |
| Advani, SH; Bhisey, AN; Kumar, A; Naik, NR; Radhika, V; Thennarasu, S | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Stimulus-specific defect in platelet aggregation in polycythemia vera.
Topics: Adenosine Diphosphate; Aged; Aged, 80 and over; Blood Platelets; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Luminescent Measurements; Middle Aged; Multiple Myeloma; Platelet Activating Factor; Platelet Aggregation; Polycythemia Vera; Tetradecanoylphorbol Acetate | 1994 |
Granulocytes from chronic myeloid leukemia (CML) patients show differential response to different chemoattractants.
Topics: Chemotactic Factors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukotriene B4; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oligopeptides; Platelet Activating Factor; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; Reference Values | 1996 |